The t(4;12): By FISH PDGFR Alpha Rearrangement (HES) Blood Test, also referred to as the FIP1L1-PDGFRA Fusion Gene Test, 4q12 Rearrangement FISH, or CHIC2 Deletion Test, is a specialized genetic test that detects a specific chromosomal abnormality called the t(4;12) translocation. This translocation results in the fusion of two genes, FIP1L1 and PDGFRα, leading to the overproduction of a growth-stimulating protein. This abnormality is associated with various blood disorders characterized by high levels of eosinophils (a type of white blood cell), including hypereosinophilia (HE) and hypereosinophilic syndrome (HES).
What is the t(4;12): By FISH PDGFR Alpha Rearrangement (HES) Blood Test?
This test involves analyzing a blood sample using fluorescence in situ hybridization (FISH) technology. FISH utilizes fluorescent probes that bind to specific DNA sequences on chromosomes, allowing for the visualization and identification of the t(4;12) translocation and the resulting FIP1L1-PDGFRA fusion gene.
Why Get Tested for t(4;12): By FISH PDGFR Alpha Rearrangement?
Preparing for the t(4;12): By FISH PDGFR Alpha Rearrangement Test
FAQs About the t(4;12): By FISH PDGFR Alpha Rearrangement Test
What are normal results for this test? A normal result means that the t(4;12) translocation and FIP1L1-PDGFRA fusion gene were not detected in your blood sample.
What does a positive result mean? A positive result indicates the presence of the t(4;12) translocation and the FIP1L1-PDGFRA fusion gene, suggesting a diagnosis of a specific subtype of HE or HES. This information is crucial for guiding targeted therapy with tyrosine kinase inhibitors.
Are there any risks associated with this test? The test involves a simple blood draw, carrying minimal risks like slight pain or bruising at the needle insertion site.
Key Features of One Health Assist
In Conclusion
The t(4;12): By FISH PDGFR Alpha Rearrangement (HES) Blood Test is a powerful diagnostic tool for identifying a specific genetic abnormality associated with certain types of hypereosinophilia (HE) and hypereosinophilic syndrome (HES). Early detection and targeted treatment can significantly improve outcomes for individuals with these conditions. If you have concerns about HE, HES, or unexplained elevated eosinophil levels, consult your healthcare provider and consider booking this test through One Health Assist for a convenient and informative experience. Take control of your health and seek answers today.